Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug resistance: focus in hematology.

G Carulli1, M Petrini

  • 1Servizio di Ematologia, Clinica Medica I, Università, Pisa, Italy.

Haematologica
|July 1, 1990
PubMed
Summary

Multidrug resistance (MDR) in cancer chemotherapy is often caused by P-170 glycoprotein, which reduces drug accumulation. Targeting P-170 offers new therapeutic strategies for hematological malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic lip edema and pain secondary to lip augmentation procedure: histological, scanning electron microscopy and X-ray microanalysis evaluation.

European review for medical and pharmacological sciences·2023
Same author

Carboxytherapy with oxygen propulsion treatment of cellulite is more effective in women not affected by periodontal disease.

Journal of biological regulators and homeostatic agents·2021
Same author

Contributi scientifici in memoria di Antonio Fusco.

La Clinica terapeutica·2020
Same author

The Vital Importance of Gum Health.

Journal of dental research·2020
Same author

Effects of a novel gel containing 5-aminolevulinic acid and red LED against bacteria involved in peri-implantitis and other oral infections.

Journal of photochemistry and photobiology. B, Biology·2020
Same author

Microbiological evaluation of environmental cleanliness in haematopoietic cell transplant patient rooms: implementing JACIE standards.

The Journal of hospital infection·2019

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Chemoresistance, particularly multidrug resistance (MDR), is a major challenge in cancer therapy.
  • MDR is frequently associated with the overexpression of a membrane glycoprotein, P-170.
  • P-170 binds ATP, reducing the intracellular accumulation of various antineoplastic drugs used in hematological cancers.

Purpose of the Study:

  • To explore the role of P-170 in chemoresistance in hematological malignancies.
  • To review strategies for overcoming P-170-mediated drug resistance.
  • To discuss the potential of P-170 as a therapeutic target.

Main Methods:

  • Utilized monoclonal antibodies and probes for in vitro and in vivo studies of P-170.
  • Investigated P-170's structure and mechanism of action.
  • Reviewed existing literature on P-170 expression and therapeutic interventions.

Main Results:

  • P-170 is expressed in variable percentages across leukemia, myelodysplastic syndromes, myeloma, and lymphoma.
  • P-170 activity can be antagonized by competitive binding drugs or calcium antagonists.
  • Patients with P-170-positive cells may benefit from treatments with drugs not effluxed by P-170.

Conclusions:

  • P-170 expression is a significant factor in chemoresistance in hematological cancers.
  • Therapeutic strategies include using alternative drugs or inhibiting P-170 function.
  • Targeting P-170, potentially with immunotoxins, presents a promising avenue for novel treatment protocols.

Related Experiment Videos